CMS's Hemp CBD Program Has A Physician Problem - MMJ Appeal Pending
In a recent interview Vantage Hemp's Chief Medical Officer says healthcare needs standardized, reproducible products and controlled clinical trials. as CMS carries its cannabinoid initiative into the 10-year LEAD Medicare model
